This announcement is a separate document:
康弘药业：北京市通商（深圳）律师事务所关于成都康弘药业集团股份有限公司2021年股票期权激励计划注销部分股票期权及首次授予部分股票期权第三个行权期、预留授予部分股票期权第二个行权期行权条件成就的法律意见书
Chengdu Kanghong Pharmaceutical Group: Peking Tongshang (Shenzhen) Law Firm's legal opinion on the cancellation of part of the stock options and the first grant of part of the stock options in the stock option incentive plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021, the achievement of the exercise conditions for the third exercise period, and the reserved grant of part of the stock options for the second exercise period.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.